Pyxis Oncology Inc. (PYXS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pyxis Oncology Inc.

    NASDAQ: PYXS · Real-Time Price · USD
    2.57
    0.32 (14.22%)
    At close: Oct 03, 2025, 3:59 PM
    2.57
    0.00%
    After-hours: Oct 03, 2025, 07:45 PM EDT

    Pyxis Oncology Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 19.47M 9.66M 179.29M 274.74M
    Short-Term Investments
    		 107.46M 109.63M n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 109K
    Receivables
    		 n/a 21K 598K n/a
    Inventory
    		 n/a n/a 874K n/a
    Other Current Assets
    		 4.75M 4.27M 5.41M 2.17M
    Total Current Assets
    		 132.44M 124.6M 186.61M 278.67M
    Property-Plant & Equipment
    		 22.14M 24.81M 24.77M 1.24M
    Goodwill & Intangibles
    		 2.6M 24.31M n/a n/a
    Total Long-Term Assets
    		 24.74M 49.12M 24.77M 1.35M
    Total Assets
    		 157.18M 173.73M 211.38M 280.02M
    Account Payables
    		 4.86M 3.9M 7.1M 11.95M
    Deferred Revenue
    		 n/a 7.66M n/a 6.33M
    Short-Term Debt
    		 1.45M n/a n/a 165K
    Other Current Liabilities
    		 5.94M 7.75M 1.09M 3.06M
    Total Current Liabilities
    		 17.68M 25.76M 31.63M 18.71M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 18.75M 22.26M 18.92M n/a
    Total Liabilities
    		 36.43M 48.02M 50.55M 18.71M
    Total Debt
    		 20.2M 21.33M 18.92M 165K
    Book Value
    		 120.75M 125.7M 160.82M 261.31M
    Book Value Per Share
    		 2.07 3.15 4.87 8.11
    Common Stock
    		 60K 45K 34K 32K
    Retained Earnings
    		 -363.56M -286.23M -212.44M -91.72M
    Comprehensive Income
    		 170K 63K n/a -280.02M
    Shareholders Equity
    		 120.75M 125.7M 160.82M 261.31M
    Total Investments
    		 107.46M 109.63M n/a n/a

    Add to Watchlist